About
Synosia Therapeutics is a biopharmaceutical company developing small-molecule therapies for neurological and psychiatric disorders; its programs have included candidates targeting Parkinson's disease.
Explore Synosia Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.